ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00031083
Recruitment Status : Suspended
First Posted : February 22, 2002
Last Update Posted : June 8, 2012
Sponsor:
Information provided by:
Biogen

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Primary Completion Date : No date given
  Study Completion Date : March 2004